
IceCure Medical, an Israeli company developing a minimally invasive medical device for treating tumors, recently announced that it will start offering its technology, called cryoablation, in Israel in upcoming weeks.
The company’s device is an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor and does not require hospitalization, leaves minimal to no scarring, and has a short recovery time. Destroyed tumor cells are then reabsorbed in the body over time.
The treatment, which is approved in the US and the European Union, will be available in Israel to women suffering from fibroadenomas, benign breast tumors usually found in women under 30, and for patients with malignant kidney tumors.
Article excerpts from calcalisttech.com
After a long waiting period, seven people received a new lease on life as the medical teams at Rabin Medical Center performed seven organ transplants in 48 hours.
The Abe and Irene Pollin Award of Excellence was presented to
four staff members of Rabin Medical Center for outstanding excellence
in their work.
On January 30, 2008, the American Physician
Friends of Rabin Medical Center hosted a
presentation by Dr. Moshe Salai, the Director
of the Dept. of Orthopedic Surgery at the
Rabin Medical Center.